GENPREX (GNPX) Short Interest Ratio & Short Volume $0.27 +0.01 (+4.24%) Closing price 04:00 PM EasternExtended Trading$0.27 +0.00 (+0.37%) As of 05:01 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GENPREX Short Interest DataGENPREX (GNPX) has a short interest of 2.30 million shares, representing 8.15% of the float (the number of shares available for trading by the public). This marks a -7.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.5, indicating that it would take 0.5 days of the average trading volume of 4.15 million shares to cover all short positions.Current Short Interest2,300,000 sharesPrevious Short Interest2,490,000 sharesChange Vs. Previous Month-7.63%Dollar Volume Sold Short$671.37 thousandShort Interest Ratio0.5 Days to CoverLast Record DateJune 15, 2025Outstanding Shares27,820,000 sharesFloat Size28,220,000 sharesShort Percent of Float8.15%Today's Trading Volume1,914,670 sharesAverage Trading Volume4,148,349 sharesToday's Volume Vs. Average46% Short Selling GENPREX? Sign up to receive the latest short interest report for GENPREX and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGNPX Short Interest Over TimeGNPX Days to Cover Over TimeGNPX Percentage of Float Shorted Over Time GENPREX Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/20252,300,000 shares $671.37 thousand -7.6%8.2%0.5 $0.29 5/31/20252,490,000 shares $883.95 thousand +69.4%9.2%0.5 $0.36 5/15/20251,470,000 shares $348.10 thousand -42.6%5.4%0.3 $0.24 4/30/20252,560,000 shares $742.40 thousand +57.1%10.9%0.6 $0.29 4/15/20251,630,000 shares $423.80 thousand +487.6%6.9%0.4 $0.26 3/31/2025277,400 shares $68.05 thousand -16.9%1.2%0.1 $0.25 3/15/2025333,600 shares $121.20 thousand -47.3%4.0%0.2 $0.36 2/28/2025633,100 shares $238.68 thousand -44.0%7.7%0.7 $0.38 2/15/20251,130,000 shares $498.22 thousand +505.3%13.7%1.2 $0.44 1/31/2025186,700 shares $115.49 thousand -28.6%2.3%0.2 $0.62 Get the Latest News and Ratings for GNPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for GENPREX and its competitors with MarketBeat's FREE daily newsletter. 1/15/2025261,300 shares $182.91 thousand -34.0%3.2%0.1 $0.70 12/31/2024396,100 shares $337.32 thousand -37.6%4.8%0 $0.85 12/15/2024634,600 shares $736.14 thousand +46.5%7.7%0.1 $1.16 11/30/2024433,100 shares $472.08 thousand +26.6%5.4%0 $1.09 11/15/2024342,100 shares $547.36 thousand -5.9%4.3%0 $1.60 10/31/2024363,400 shares $817.65 thousand +326.5%15.0%0 $2.25 10/15/202485,200 shares $28.49 thousand +5.2%3.5%0 $0.33 9/30/202481,000 shares $29.30 thousand -66.9%3.3%0.2 $0.36 9/15/2024244,700 shares $102.77 thousand +501.2%9.6%0.6 $0.42 8/31/202440,700 shares $27.87 thousand -83.6%1.6%0.1 $0.68 8/15/2024247,400 shares $161.28 thousand +430.9%9.7%1.1 $0.65 7/31/202446,600 shares $78.29 thousand -16.6%2.3%0.5 $1.68 7/15/202455,900 shares $111.80 thousand +10.5%2.7%0.6 $2.00 6/30/202450,600 shares $95.38 thousand -39.2%2.5%0.5 $1.89 6/15/202483,200 shares $180.54 thousand +75.9%4.0%0.8 $2.17 5/31/202447,300 shares $147.10 thousand +20.1%2.3%0.4 $3.11 5/15/202439,400 shares $96.14 thousand -21.2%1.9%0.8 $2.44 4/30/202450,000 shares $113.00 thousand +0.6%2.5%0.9 $2.26 4/15/202449,700 shares $119.28 thousand -29.0%2.7%0.6 $2.40 3/31/202470,000 shares $208.60 thousand -12.8%3.8%0.8 $2.98 3/15/202480,300 shares $324.41 thousand +23.7%5.6%1 $4.04 2/29/202464,900 shares $279.07 thousand -35.3%4.5%1 $4.30 2/15/2024100,300 shares $439.31 thousand +86.1%6.9%2 $4.38 1/31/202453,900 shares $409.64 thousand +38.6%3.7%1.1 $7.60 1/15/20241,560,000 shares $339.77 thousand +13.9%N/A4.2 $0.22 12/31/20231,370,000 shares $315.10 thousand +25.7%N/A3.6 $0.23 12/15/20231,090,000 shares $229.99 thousand -7.6%N/A3.3 $0.21 11/30/20231,180,000 shares $285.56 thousand -11.9%N/A4 $0.24 11/15/20231,340,000 shares $348.40 thousand -18.3%N/A4.5 $0.26 10/31/20231,640,000 shares $362.44 thousand -8.9%N/A4.2 $0.22Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 10/15/20231,800,000 shares $585 thousand +9.1%N/A4.2 $0.33 9/30/20231,650,000 shares $651.59 thousand -6.8%N/A3.1 $0.39 9/15/20231,770,000 shares $901.82 thousand +3.5%N/A2.5 $0.51 8/31/20231,710,000 shares $888.69 thousand -19.0%N/A2.4 $0.52 8/15/20232,110,000 shares $1.19 million -17.3%N/A2.8 $0.57 7/31/20232,550,000 shares $1.94 million +11.8%N/A3.9 $0.76 7/15/20232,280,000 shares $1.88 million -22.5%N/A3.8 $0.82 6/30/20232,940,000 shares $2.79 million +55.6%N/A4.7 $0.95 6/15/20231,890,000 shares $1.61 million -6.0%N/A4.5 $0.85 5/31/20232,010,000 shares $1.73 million +6.9%N/A4.4 $0.86 5/15/20231,880,000 shares $1.52 million -16.8%N/A3.4 $0.81 4/30/20232,260,000 shares $1.85 million +37.0%N/A4.1 $0.82 4/15/20231,650,000 shares $1.37 million -4.1%N/A3 $0.83 3/31/20231,720,000 shares $1.57 million -11.3%N/A5 $0.91 3/15/20231,940,000 shares $1.60 million -29.2%N/A4.8 $0.83 2/28/20232,740,000 shares $3.51 million +52.2%N/A7.5 $1.28 2/15/20231,800,000 shares $2.86 million +2.9%N/A5.7 $1.59 1/31/20231,750,000 shares $2.57 million +6.1%N/A9.4 $1.47 1/15/20231,650,000 shares $2.36 million +13.0%N/A9.6 $1.43 12/30/20221,460,000 shares $2.12 million -2.0%N/A8.7 $1.45 12/15/20221,490,000 shares $1.77 million -4.5%N/A13.9 $1.19 11/30/20221,560,000 shares $2.11 million +0.7%N/A15.8 $1.35 11/15/20221,550,000 shares $2.09 million -1.9%N/A12.8 $1.35 10/31/20221,580,000 shares $2.15 million -1.9%N/A6.1 $1.36 10/15/20221,610,000 shares $2.14 million -8.0%N/A6 $1.33 9/30/20221,750,000 shares $2.47 million -0.6%N/A6.7 $1.41 9/15/20221,760,000 shares $2.94 million -5.4%N/A6.8 $1.67 8/31/20221,860,000 shares $2.98 million +16.3%N/A7.2 $1.60 8/15/20221,600,000 shares $3.34 million -4.2%N/A6.6 $2.09 7/31/20221,670,000 shares $2.32 million -11.6%N/A15.1 $1.39 7/15/20221,890,000 shares $2.72 million +1.1%N/A16.3 $1.44 6/30/20221,870,000 shares $2.60 million +2.2%N/A13.9 $1.39 6/15/20221,830,000 shares $2.49 million -9.9%N/A12 $1.36 5/31/20222,030,000 shares $2.98 million +5.2%N/A10.1 $1.47 5/15/20221,930,000 shares $2.93 million -1.0%N/A7 $1.52 4/30/20221,950,000 shares $3.12 million -3.0%N/A5.6 $1.60 4/15/20222,010,000 shares $4.00 million +8.1%N/A3.5 $1.99 3/31/20221,860,000 shares $4.20 million -3.1%N/A1.4 $2.26 3/15/20221,920,000 shares $3.88 million -20.0%N/A0.3 $2.02 2/28/20222,400,000 shares $5.47 million -19.2%N/A0.4 $2.28 2/15/20222,970,000 shares $7.01 million -13.2%N/A0.5 $2.36 1/31/20223,420,000 shares $6.81 million -23.8%N/A0.6 $1.99 1/15/20224,490,000 shares $10.15 million +113.8%N/A0.7 $2.26 12/31/20212,100,000 shares $2.75 million -3.7%N/A0.4 $1.31 12/15/20212,180,000 shares $2.83 million -1.4%N/A5.1 $1.30 11/30/20212,210,000 shares $3.20 million -2.6%N/A5.4 $1.45 11/15/20212,270,000 shares $4.65 million -0.9%N/A5.7 $2.05 10/29/20212,290,000 shares $5.34 million +2.7%N/A6.1 $2.33 10/15/20212,230,000 shares $5.37 million -2.6%N/A5.7 $2.41 9/30/20212,290,000 shares $6.14 million -2.6%N/A6 $2.68Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 9/15/20212,350,000 shares $6.51 million +2.6%N/A4.8 $2.77 8/31/20212,290,000 shares $7.21 million -2.6%N/A4.3 $3.15 8/13/20212,350,000 shares $6.49 million -10.0%N/A4.1 $2.76 7/30/20212,610,000 shares $7.73 million -6.5%N/A4.5 $2.96 7/15/20212,790,000 shares $8.15 million No Change6.6%4.5 $2.92 6/30/20212,790,000 shares $9.35 million -24.8%6.6%4 $3.35 6/15/20213,710,000 shares $13.21 million -7.3%8.8%5.1 $3.56 5/28/20214,000,000 shares $14.96 million -2.7%9.4%5.2 $3.74 5/14/20214,110,000 shares $12.78 million -1.4%N/A4.4 $3.11 4/30/20214,170,000 shares $16.30 million No ChangeN/A3.7 $3.91 4/15/20214,170,000 shares $16.97 million -3.9%N/A2.9 $4.07 3/31/20214,340,000 shares $17.66 million +24.4%N/A2.9 $4.07 3/15/20213,490,000 shares $18.43 million +9.8%N/A1.9 $5.28 2/26/20213,180,000 shares $16.89 million -2.8%N/A1.8 $5.31 2/12/20213,270,000 shares $22.82 million -22.0%N/A1.9 $6.98 1/29/20214,190,000 shares $18.73 million +3.7%N/A2.7 $4.47 1/15/20214,040,000 shares $15.47 million +27.0%N/A3.1 $3.83 12/31/20203,180,000 shares $14.06 million +0.6%N/A2.9 $4.42 12/15/20203,160,000 shares $10.40 million -6.2%N/A3.3 $3.29 11/30/20203,370,000 shares $10.41 million +12.3%N/A5.4 $3.09 11/15/20203,000,000 shares $9.48 million -1.0%N/A4.2 $3.16 10/30/20203,030,000 shares $10.70 million +2.0%N/A3.4 $3.53 10/15/20202,970,000 shares $10.96 million -5.7%N/A3.3 $3.69 9/30/20203,150,000 shares $10.58 million -9.2%N/A2.5 $3.36 9/15/20203,470,000 shares $13.12 million -8.9%N/A2.3 $3.78 8/31/20203,810,000 shares $15.09 million +7.3%N/A2.3 $3.96 8/14/20203,550,000 shares $15.23 million -9.9%N/A2 $4.29 7/31/20203,940,000 shares $13.28 million +1.8%N/A2.3 $3.37 7/15/20203,870,000 shares $11.46 million -4.2%N/A1.4 $2.96 GNPX Short Interest - Frequently Asked Questions What is GENPREX's current short interest? Short interest is the volume of GENPREX shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 2,300,000 shares of GNPX short. 8.15% of GENPREX's shares are currently sold short. Learn More on GENPREX's current short interest. What is a good short interest percentage for GENPREX? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.15% of GENPREX's floating shares are currently sold short. Is GENPREX's short interest increasing or decreasing? GENPREX saw a decline in short interest in June. As of June 15th, there was short interest totaling 2,300,000 shares, a decline of 7.6% from the previous total of 2,490,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is GENPREX's float size? GENPREX currently has issued a total of 27,820,000 shares. Some of GENPREX's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. GENPREX currently has a public float of 28,220,000 shares. How does GENPREX's short interest compare to its competitors? 8.15% of GENPREX's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to GENPREX: Cara Therapeutics, Inc. (1.74%), Tenax Therapeutics, Inc. (8.58%), Lisata Therapeutics, Inc. (0.46%), Cyclo Therapeutics, Inc. (3.55%), FibroBiologics Inc. (4.92%), NanoViricides, Inc. (0.59%), BioAtla, Inc. (7.97%), Chemomab Therapeutics Ltd. Sponsored ADR (1.04%), ALX Oncology Holdings Inc. (16.09%), VYNE Therapeutics Inc. (2.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short GENPREX stock? Short selling GNPX is an investing strategy that aims to generate trading profit from GENPREX as its price is falling. GNPX shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against GENPREX? A short squeeze for GENPREX occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GNPX, which in turn drives the price of the stock up even further. How often is GENPREX's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNPX, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Cara Therapeutics Short Squeeze Tenax Therapeutics Short Squeeze Lisata Therapeutics Short Squeeze Cyclo Therapeutics Short Squeeze FibroBiologics Short Squeeze NanoViricides Short Squeeze BioAtla Short Squeeze Chemomab Therapeutics Short Squeeze ALX Oncology Short Squeeze VYNE Therapeutics Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GNPX) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredNobel Prize Material Finally Goes CommercialA Nobel Prize–winning material just got its biggest breakthrough in 30 years. A little-known company has cr...True Market Insiders | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GENPREX Please log in to your account or sign up in order to add this asset to your watchlist. Share GENPREX With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNPX Stock Alerts